Baxter To Spend $180 Million In Turkey To Test Pre-Dialysis Immunity Drug
This article was originally published in PharmAsia News
Executive Summary
Turkey officials announced Baxter plans to invest $180 million in the country to develop a drug to increase the immunity of kidney patients in advance of dialysis treatments.